[
  {
    "criterion": "Reward for capturing all patient-reported concerns and relevant symptom details (increased hunger since starting glipizide, anxiety about weight gain, resolved cough after stopping lisinopril, new ankle swelling since starting losartan) with timing/context in the History of Present Illness.",
    "weight": 20,
    "sense": "positive"
  },
  {
    "criterion": "Reward for listing each current medication with correct name and dose (metformin 500 mg, glipizide 5 mg, losartan 50 mg), documenting adherence/effectiveness, and explicitly linking glipizide to increased appetite and losartan to ankle edema.",
    "weight": 20,
    "sense": "positive"
  },
  {
    "criterion": "Reward for documenting a concrete, patient-specific safety monitoring plan including: daily home glucose logs, regular weight tracking, hypoglycemia education, ankle-swelling monitoring strategy, renal function & potassium labs ordered, and a follow-up timeframe.",
    "weight": 25,
    "sense": "positive"
  },
  {
    "criterion": "Reward for noting evidence-based management options (dietary counseling per ADA guidance, consideration of switching from sulfonylurea to weight-neutral agent if appetite/weight gain persists, and dose adjustment or alternative antihypertensive if edema continues).",
    "weight": 15,
    "sense": "positive"
  },
  {
    "criterion": "Penalize for omission of objective data critical for safe decision-making, specifically missing vital signs (blood pressure, weight), physical exam findings of ankle edema, or recent glucose/A1c values.",
    "weight": 15,
    "sense": "negative"
  },
  {
    "criterion": "Penalize for redundant chart copy or irrelevant verbose text that does not add encounter-specific information.",
    "weight": 5,
    "sense": "negative"
  }
]